Mpm Bioimpact LLC’s Palvella Therapeutics Inc Ne Position
Does Mpm Bioimpact LLC own Palvella Therapeutics Inc Ne (PVLA)? Yes — 206.4K shares worth $26M (+1.99% of its 13F portfolio) as of Q1 2026, up from 205.7K shares the prior filed quarter.
Position Value
$26M
Q1 2026
Shares
206.4K
% of Portfolio
+1.99%
Quarters Held
3
currently held
Position History PVLA
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of PVLA.